Metastatic ependymoma: A multi-institutional retrospective analysis of prognostic factors

Pediatric Blood and Cancer

Volumn 50, Issue 2, 2008, Pages 231-235

  Zacharoulis, Stergios ^a   Ji, Lingyun ^b   Pollack, Ian F ^c   Duffner, Patricia ^d   Geyer, Russel ^e   Grill, Jacques ^f   Schild, Steven ^g   Jaing, Tang Her ^h   Massimino, Maura ⁱ   Finlay, Jonathan ^b   Sposto, Richard ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g MAYO CLINIC   (United States)

^h CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

ⁱ NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Metastatic ependymoma; Prognosis

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ADJUVANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; EPENDYMOMA; FEMALE; FOLLOW UP; HUMAN; INFANT; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NEWBORN; POSTERIOR CRANIAL FOSSA TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 37549050942     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21276     Document Type: Article

References (24)

1. Agaoglu FY, Ayan I, Dizdar Y, et al. Ependymal tumors in childhood. Pediatr Blood Cancer 2005;45:298-303.
2. Chamberlain MC. Ependymomas. Curr Neurol Neurosci Rep 2003;3:193-199.
3. Ernestus RI, Wilcke O. Spinal metastases of intracranial ependymomas. Four case reports and review of the literature. Neurosurg Rev 1990;13:147-154.
4. Foreman NK, Love S, Thorne R. Intracranial ependymomas: Analysis of prognostic factors in a population-based series. Pediatr Neurosurg 1996;24:119-125.
5. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 2005;23:7621-7631.
6. Varan A, Sari N, Akalan N, et al. Extraneural metastasis in intracranial tumors in children: The experience of a single center. J Neurooncol 2006;79:187-190.
7. Subramanian A, Harris A, Piggott K, et al. Metastasis to and from the central nervous system - the 'relatively protected site'. Lancet Oncol 2002;3:498-507.
8. Schweitzer T, Vince GH, Herbold C, et al. Extraneural metastases of primary brain tumors. J Neurooncol 2001;53:107-114.
9. Graf M, Blaeker H, Otto HF. Extraneural metastasizing ependymoma of the spinal cord. Pathol Oncol Res 1999;5:56-60.
10. Rezai AR, Woo HH, Lee M, et al. Disseminated ependymomas of the central nervous system. J Neurosurg 1996;85:618-624.
11. Bouffet E, Perilongo G, Canete A, et al. Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 1998;30:319-329; discussion 329-331.
12. Chiu JK, Woo SY, Ater J, et al. Intracranial ependymoma in children: Analysis of prognostic factors. J Neurooncol 1992;13:283-290.
13. Engelhard HH, Corsten LA. Leptomeningeal metastasis of primary central nervous system (CNS) neoplasms. Cancer Treat Res 2005;125:71-85.
14. Jaing TH, Wang HS, Tsay PK, et al. Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas. J Neurooncol 2004;68:255-261.
15. Paulino AC, Wen BC, Buatti JM, et al. Intracranial ependymomas: An analysis of prognostic factors and patterns of failure. Am J Clin Oncol 2002;25:117-122.
16. Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: Long-term outcome and prognostic factors. Neurosurgery 1995;37:655-666; discussion 666-667.
17. Duffner PK, Krischer JP, Sanford RA, et al. Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 1998;28:215-222.
18. Massimino M, Gandola L, Giangaspero F, et al. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: Final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys 2004;58:1336-1345.
19. Zacharoulis S, Levy A, Chi SN, et al. Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue. Pediatr Blood Cancer 2007;49:34-340.
20. Grill J, Le Deley MC, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol 2001;19:1288-1296.
21. Schild SE, Nisi K, Scheithauer BW, et al. The results of radiotherapy for ependymomas: The Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1998;42:953-958.
22. Akyuz C, Emir S, Akalan N, et al. Intracranial ependymomas in childhood - a retrospective review of sixty-two children. Acta Oncol 2000;39:97-100.
23. Perilongo G, Massimino M, Sotti G, et al. Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group. Med Pediatr Oncol 1997;29:79-85.
24. Taylor MD, Poppleton H, Fuller C, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005;8:323-335.